Direct comparison of PET/CT and MRI to predict the pathological response to neoadjuvant chemotherapy in breast cancer: a meta-analysis
Abstract Both PET/CT and breast MRI are used to assess pathological complete response to neoadjuvant chemotherapy (NAC) in patients with breast cancer. The aim is to compare the utility of PET/CT and breast MRI by using head-to-head comparative studies. Literature databases were searched prior to Ju...
Guardado en:
Autores principales: | Lihua Chen, Qifang Yang, Jing Bao, Daihong Liu, Xuequan Huang, Jian Wang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f1db3b59853c4157adee1ce54cafba3b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
A Study on Clinical and Pathological Responses to Neoadjuvant Chemotherapy in Breast Carcinoma
por: Kunnuru SKR, et al.
Publicado: (2020) -
Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer: A Pairwise and Network Meta-Analysis of Pathological Complete Response
por: Zeng-Jie Weng MM, et al.
Publicado: (2021) -
Metabolic Radiomics for Pretreatment 18F-FDG PET/CT to Characterize Locally Advanced Breast Cancer: Histopathologic Characteristics, Response to Neoadjuvant Chemotherapy, and Prognosis
por: Seunggyun Ha, et al.
Publicado: (2017) -
Multimodal deep learning models for the prediction of pathologic response to neoadjuvant chemotherapy in breast cancer
por: Sunghoon Joo, et al.
Publicado: (2021) -
Towards integration of 64Cu-DOTA-trastuzumab PET-CT and MRI with mathematical modeling to predict response to neoadjuvant therapy in HER2 + breast cancer
por: Angela M. Jarrett, et al.
Publicado: (2020)